|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 17/10 | Viatris Gets FDA Approval for Ryzumvi in the Treatment of Presbyopia | MT |
| 17/10 | Viatris Inc. Receives U.S. Fda Approval for Ryzumvi® for Treatment of Presbyopia in Adults | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.49% | +8.54% | +11.34% | +8.87% | +19.45% | +59.89% | +117.27% | +429.76% | +1,533.99% | 1,10600Cr | |
| +2.19% | -1.66% | -3.94% | +2.50% | +25.32% | +34.23% | +70.27% | +58.27% | +126.34% | 61TCr | |
| +2.26% | +2.83% | +9.52% | +13.59% | +26.52% | +25.92% | +98.65% | +169.04% | +370.58% | 50TCr | |
| +2.58% | +8.31% | +9.28% | +16.67% | +18.80% | +37.43% | +63.51% | +8.93% | +66.77% | 37TCr | |
| +3.25% | +1.96% | +0.97% | +16.31% | +40.89% | +74.90% | +47.67% | +86.56% | +139.70% | 35TCr | |
| +1.85% | +5.45% | +9.90% | +1.20% | +15.42% | +21.38% | +49.26% | +64.95% | +68.89% | 29TCr | |
| +1.76% | +4.92% | +0.94% | +0.19% | -8.50% | +0.48% | +20.31% | +44.39% | +155.40% | 26TCr | |
| +3.29% | +5.12% | +13.82% | +19.83% | +34.11% | +46.90% | +56.43% | +112.27% | +172.50% | 23TCr | |
| +2.25% | +4.04% | +4.26% | +16.55% | +27.51% | +27.44% | +99.53% | +133.95% | +113.40% | 19TCr | |
| +1.83% | +1.87% | -7.23% | -20.82% | -19.69% | -23.77% | -61.82% | -22.03% | +89.07% | 17TCr | |
| +2.28% | +6.02% | +8.86% | +20.20% | +20.92% | +22.85% | -3.46% | -28.46% | -7.64% | 17TCr | |
| +2.53% | +1.51% | +1.24% | +5.97% | +13.52% | +23.47% | +41.08% | +177.57% | +528.93% | 13TCr | |
| +4.84% | +7.12% | -2.19% | +1.55% | +14.35% | +41.37% | +9.21% | +7.10% | +23.68% | 12TCr | |
| +1.95% | +7.78% | +17.78% | +22.43% | +25.58% | +31.06% | +127.26% | +408.48% | +539.35% | 12TCr | |
| +0.73% | +5.51% | -0.48% | -2.50% | +2.41% | +14.98% | +28.76% | +6.23% | -10.22% | 9.9TCr | |
| +3.62% | +2.77% | -0.63% | -4.86% | -11.05% | -14.87% | -25.53% | -10.95% | +7.38% | 9.54TCr | |
| +6.69% | +13.26% | +57.15% | +291.59% | +720.89% | +830.72% | +193.89% | -27.44% | - | 9.06TCr | |
| +3.25% | +5.86% | +2.88% | +19.33% | +4.61% | +39.69% | -0.14% | +46.25% | +119.21% | 7.81TCr | |
| +1.42% | +5.59% | +12.75% | +7.41% | +19.41% | +30.48% | -2.43% | -24.94% | +48.19% | 7.04TCr | |
| Average | +1.54% | +2.44% | +7.70% | +22.95% | +52.13% | +69.71% | +48.93% | +86.31% | +226.97% | 26.51TCr | |
| Weighted average by Cap. | +0.82% | +2.35% | +6.78% | +13.75% | +31.71% | +50.54% | +67.76% | +153.33% | +467.61% |
- Stock Market
- Stocks
- VTRS Stock
- Stock
- Sector Mylan Inc
Select your edition
All financial news and data tailored to specific country editions
